Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.19.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2019
Jun. 30, 2018
Assets:    
Cash and cash equivalents $ 30,154 $ 14,817
Accounts receivable 285 215
Inventory 94 58
Other current assets 1,288 790
Total current assets 31,821 15,880
Property and equipment, net 15,178 12,820
Intangibles, net 388 264
Assets held for sale, net 300 333
Other assets 262 11
Total Assets 47,949 29,308
Current Liabilities:    
Accounts payable and accrued expenses 3,211 2,593
Deferred revenue 5 53
Total current liabilities 3,216 2,646
Long-term Liabilities:    
Contingent real estate liability 445 1,230
Convertible notes payable, net 18,215 11,465
Other long-term liabilities 118 117
Total long-term liabilities 18,778 12,812
Total Liabilities 21,994 15,458
Stockholders' Equity    
Preferred Stock, par value $0.001: 5,000,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 45,000,000 shares authorized; 30,140,955 and 22,203,437 shares issued and outstanding at June 30, 2019 and June 30, 2018, respectively 30 22
Additional paid in capital 93,399 52,074
Accumulated deficit (67,474) (38,246)
Total Stockholders' Equity 25,955 13,850
Total Liabilities and Stockholders' Equity $ 47,949 $ 29,308